The “Medical Bypass”: new drugs to strike obesity
Pharmaceutical Technology
NOVEMBER 30, 2022
However, there has recently been a boom in interest and research in anti-obesity therapeutics. Anti-obesity therapeutic landscape. The company’s weight loss drug Saxenda (liraglutide) won an approval for chronic weight management in December 2014, and Wegovy (semaglude) got the same tag in 2021. compared to a 5.1% Uzbekistan.
Let's personalize your content